LRRN1
Leucine-rich repeat neuronal protein 1
Also known as: FIGLER3, LRRN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UXK5
- Gene
- LRRN1
- Ensembl
- ENSG00000175928
- Chromosome
- 3
- Canonical length
- 716 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Golgi apparatus,Centriolar satellite,Basal body
OverviewNCBI Gene
Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be located in membrane. Predicted to be active in extracellular matrix and extracellular space. Biomarker of stomach cancer. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
716 residues, UniProt reviewed canonical sequence.
>Q6UXK5|LRRN1
1 MARMSFVIAA CQLVLGLLMT SLTESSIQNS ECPQLCVCEI RPWFTPQSTY REATTVDCND
61 LRLTRIPSNL SSDTQVLLLQ SNNIAKTVDE LQQLFNLTEL DFSQNNFTNI KEVGLANLTQ
121 LTTLHLEENQ ITEMTDYCLQ DLSNLQELYI NHNQISTISA HAFAGLKNLL RLHLNSNKLK
181 VIDSRWFDST PNLEILMIGE NPVIGILDMN FKPLANLRSL VLAGMYLTDI PGNALVGLDS
241 LESLSFYDNK LVKVPQLALQ KVPNLKFLDL NKNPIHKIQE GDFKNMLRLK ELGINNMGEL
301 VSVDRYALDN LPELTKLEAT NNPKLSYIHR LAFRSVPALE SLMLNNNALN AIYQKTVESL
361 PNLREISIHS NPLRCDCVIH WINSNKTNIR FMEPLSMFCA MPPEYKGHQV KEVLIQDSSE
421 QCLPMISHDS FPNRLNVDIG TTVFLDCRAM AEPEPEIYWV TPIGNKITVE TLSDKYKLSS
481 EGTLEISNIQ IEDSGRYTCV AQNVQGADTR VATIKVNGTL LDGTQVLKIY VKQTESHSIL
541 VSWKVNSNVM TSNLKWSSAT MKIDNPHITY TARVPVDVHE YNLTHLQPST DYEVCLTVSN
601 IHQQTQKSCV NVTTKNAAFA VDISDQETST ALAAVMGSMF AVISLASIAV YFAKRFKRKN
661 YHHSLKKYMQ KTSSIPLNEL YPPLINLWEG DSEKDKDGSA DTKPTQVDTS RSYYMWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRRN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 16 nTPM
- basal ganglia: 9.2 nTPM
- amygdala: 6.7 nTPM
- hippocampal formation: 6 nTPM
- testis: 5.6 nTPM
- skeletal muscle: 5.4 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 550 nCPM
- brain inhibitory neurons: 157 nCPM
- ependymal cells: 131 nCPM
- pituitary stem cells: 113 nCPM
- sertoli cells: 106 nCPM
- astrocytes: 81 nCPM
Immune cell
- neutrophil: 0.4 nTPM
- eosinophil: 0.3 nTPM
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 45 nTPM
- midbrain: 37 nTPM
- medulla oblongata: 36 nTPM
- pons: 35 nTPM
- basal ganglia: 34 nTPM
- amygdala: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine-rich flanking region, C-terminal
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Leucine-rich repeat domain superfamily
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Leucine-rich repeat and fibronectin type-III domain-containing
- Immunoglobulin I-set domain
- Leucine rich repeat
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRRN1 as an antibody target. Whether an autoantibody or antibody against LRRN1 could matter depends on whether native LRRN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRRN1 is annotated at the cell surface, where native LRRN1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LRRN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...